Kyowa Kirin Co Ltd
F:KY4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kyowa Kirin Co Ltd
F:KY4
|
JP |
|
7
|
7-Eleven Malaysia Holdings Bhd
KLSE:SEM
|
MY |
|
E
|
Elisa Oyj
XMUN:EIA
|
FI |
Intrinsic Value
The intrinsic value of 
Kyowa Kirin Co Ltd (KY4) under the Base Case is 15.44 EUR per share.
Compared with the current market price of 12.6 EUR, the stock appears
Undervalued by 18% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Kyowa Kirin Does
Kyowa Kirin is a Japanese pharmaceutical company that develops, makes, and sells prescription medicines. Its main business is creating drugs for serious conditions such as blood disorders, kidney-related diseases, and rare diseases, then bringing those medicines to hospitals and specialists who treat those patients. It also works on research and development, which is the starting point for its future drug pipeline.
- Headquarters
- Japan JP
- Employees
- 5 161
- IPO date
- Aug 22, 1949
Revenue & Expenses Breakdown
Kyowa Kirin Co Ltd
Earnings Waterfall
Kyowa Kirin Co Ltd
The intrinsic value for Kyowa Kirin Co Ltd (KY4) under the Base Case is 15.44 EUR.
Compared with the current market price of 12.6 EUR, the stock appears Undervalued by 18% .